Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -13.20 is 16% above its 5-year average of -15.68, near the high end of its 5-year range (-23.76–-10.32).
13.39% above its 12-month average of -15.24.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -1.92.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 21 comparable quarters.
EARNINGS PER SHARE (EPS)
-13.20
EARNINGS PER SHARE (EPS) AVG TTM
-15.24
EARNINGS PER SHARE (EPS) AVG 3Y
-17.58
EARNINGS PER SHARE (EPS) AVG 5Y
-15.68
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+13.39%
CURRENT VS 3Y AVG
+24.91%
CURRENT VS 5Y AVG
+15.82%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Fractyl Health, Inc.
Market Cap
$58.77M
Earnings Per Share (EPS)
-13.20
TTM Avg
-15.24
3Y Avg
-17.58
5Y Avg
-15.68
Market Cap
$57.20M
Earnings Per Share (EPS)
N/A
TTM Avg
-3.23
3Y Avg
-2.68
5Y Avg
-2.37
Market Cap
$59.76M
Earnings Per Share (EPS)
-2.39
TTM Avg
-2.92
3Y Avg
-5.17
5Y Avg
-5.77
Market Cap
$60.43M
Earnings Per Share (EPS)
N/A
TTM Avg
-19.12
3Y Avg
-29.60
5Y Avg
-38.42
Market Cap
$56.71M
Earnings Per Share (EPS)
-0.39
TTM Avg
-0.75
3Y Avg
-0.80
5Y Avg
-0.90
Market Cap
$56.43M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.64
3Y Avg
-4.21
5Y Avg
-9.38
Market Cap
$63.02M
Earnings Per Share (EPS)
-1.09
TTM Avg
-1.47
3Y Avg
-0.85
5Y Avg
-0.92
Market Cap
$54.90M
Earnings Per Share (EPS)
-0.35
TTM Avg
-0.57
3Y Avg
-0.69
5Y Avg
-0.62
Market Cap
$63.41M
Earnings Per Share (EPS)
-2.02
TTM Avg
-7.29
3Y Avg
-26.82
5Y Avg
-38.33
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fractyl Health, Inc. (GUTS) | $58.77M | -13.20 | -15.24 | -17.58 | -15.68 |
| Boundless Bio, Inc. (BOLD)vs › | $57.20M | N/A | -3.23 | -2.68 | -2.37 |
| MiNK Therapeutics, Inc. (INKT)vs › | $59.76M | -2.39 | -2.92 | -5.17 | -5.77 |
| Adicet Bio, Inc. (ACET)vs › | $60.43M | N/A | -19.12 | -29.60 | -38.42 |
| Aldeyra The (ALDX)vs › | $56.71M | -0.39 | -0.75 | -0.80 | -0.90 |
| Connect Biopharma Holdings Limited (CNTB)vs › | $56.43M | N/A | -0.64 | -4.21 | -9.38 |
| InterCure Ltd. (INCR)vs › | $63.02M | -1.09 | -1.47 | -0.85 | -0.92 |
| Spectral AI, Inc. (MDAI)vs › | $54.90M | -0.35 | -0.57 | -0.69 | -0.62 |
| Kalaris Therapeutics Inc (KLRS)vs › | $63.41M | -2.02 | -7.29 | -26.82 | -38.33 |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $53.15M | -8.95 | -8.42 | -12.89 | -25.33 |
Trailing EPS (TTM)
$-13.20
Forward EPS (Est.)
$-0.34
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -11.04 |
| 2024-12-31 | -19.44 |
| 2023-12-31 | -23.76 |
| 2022-12-31 | -16.08 |
| 2021-12-31 | -13.44 |
| 2020-12-31 | -10.32 |
| 2019-12-31 | -7.68 |
